Mometason furoate levels [1]

Chest

Volumn 120, Issue 3, 2001, Pages 1034-1035

  Lipworth, B J ^a   Affrime, M B ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE; MOMETASONE FUROATE; PLACEBO; TETRACOSACTIDE; TRIAMCINOLONE;

ADRENAL SUPPRESSION; ALLERGIC RHINITIS; AREA UNDER THE CURVE; ASTHMA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG STORAGE; DRUG URINE LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS DISEASE; INSULIN TOLERANCE TEST; LETTER; LIPOPHILICITY; PARAMETER; PRIORITY JOURNAL; STEADY STATE;

EID: 0034834847     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3.1034     Document Type: Letter

References (5)

1. LB Affrime T Kosoglou M Thonoor Mometasone furoate has minimal effects on hypothalamic-pituitary-adrenal axis when delivered at high doses Chest 2000 1538 1546
2. BJ Lipworth Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis Arch Intern Med 159 1999 941 955
3. AM Wilson LC McFarlane BJ Lipworth Effects of intranasal corticosteroid on adrenal, bone and blood markers of systemic activity in allergic rhinitis J Allergy Clin Immunol 102 1998 598 604
4. M Affrime F Cuss D Padhi Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers J Clin Pharmacol 40 2000 1227 1236
5. B Olsson Aerosol particle generation from dry-powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med 8 1995 S13 S19